Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Global Health|July 5, 2022
COVID-19 disease severity in persons infected with the Omicron variant compared with the Delta variant in QatarAdeel A Butt, Soha R Dargham, Patrick Tang, et al.Journal of Medical Virology|September 23, 2020
Convalescent plasma for the treatment of patients with severe coronavirus disease 2019: A preliminary reportAli S Omrani, Ahmed Zaqout, Anas Baiou, et al.Journal of Proteome Research|February 3, 2026
Longitudinal Plasma Proteome of Pfizer/BNT162b2 Pre- and Postbooster Vaccinated Healthy Individuals Reveals Distinct Protein Profiles upon SARS-CoV-2 Spike Protein StimulationThesni Raheed, Lubna Therachiyil, Varghese Inchakalody, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 11, 2022
Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron VariantAdeel A Butt, Soha R Dargham, Srusvin Loka, et al.Frontiers in Immunology|April 11, 2025
Longitudinal cellular and humoral immune responses following COVID-19 BNT162b2-mRNA-based booster vaccination of craft and manual workers in QatarRemy Thomas, Ahmed Zaqout, Bakhita Meqbel, et al.Frontiers in Immunology|May 11, 2026
Post-booster longitudinal plasma proteomic changes following BNT162b2 COVID-19 vaccination in QatarSana Bentebbal, Ahmed Zaqout, Bakhita Meqbel, et al.Frontiers in Immunology|February 23, 2023
Persistence of spike-specific immune responses in BNT162b2-vaccinated donors and generation of rapid ex-vivo T cells expansion protocol for adoptive immunotherapy: A pilot studySarra Mestiri, Maysaloun Merhi, Varghese P Inchakalody, et al.BMC Infectious Diseases|October 20, 2020
The first consecutive 5000 patients with Coronavirus Disease 2019 from Qatar; a nation-wide cohort studyAli S Omrani, Muna A Almaslamani, Joanne Daghfal, et al.Pageof 2